FinVector Oy and Kuopion kaupunki - City of Kuopio have signed an agreement under which FinVector acquires two plots of land located in the Savilahti area. One is where the company’s new gene therapy manufacturing site, Finport, is being built, and the other is the adjacent plot neighbouring the site. The total value of the acquisition is slightly under 3.9 million EUR and the total area of the plots is almost 1.6 hectares. Please read the full release from our website: https://lnkd.in/dUptu-Bv 📷 From left to right: Matthias Krieger, PhD, Managing Director of FinVector; Soile Lahti, Mayor of Kuopio; Tero Oinonen, Administration Director of Kuopio. #FinVector #Kuopio #EmbracingLife #DeliveringHope #CapitalOfGoodLife
Very good 😊
StrategicHealthcare Visionary: A nurse lead in innovative projects for optimal patient care
7moVery good. I Aspire to be part of FinVector sucess story as the company expands